Wisconsin Settles With Boehringer Ingelheim

CHICAGO—Wisconsin Attorney General J.B. Van Hollen (R) April 20 announced that the state reached a $7.75 million settlement agreement with Boehringer Ingelheim and related companies resolving allegations that the companies reported fictitious prices to deceive the Medicaid pharmaceutical reimbursement system (Wisconsin v. Abbott Laboratories).

The companies are Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc., and subsidiaries Boehringer Ingelheim Roxane Inc., Ben Venue Laboratories Inc., and Roxane Laboratories Inc. The drug companies allegedly reported “grossly inflated” average wholesale prices to a pricing compendia. The state Medicaid program used the compendia for the payment or reimbursement of pharmacists for Medicaid recipients, allegedly ...